1. Abramsky, O., Carmon, A. and Lavy, S. (1971). Combined treatment with propranolol and levodopa. J. NeuroZ. Sci. 14 ,491–494.
2. Barbeau, A. (1969a). Parkinson’s disease as a systemic disorder. In Third Symposium on Parkinson’s Disease (Gillingham, F.J. and Donaldson, I.M.L., Eds.) pp. 66–73. E.S. Livingstone Ltd., Edinburgh and London.
3. Barbeau, A. (1969b). L-dopa therapy in Parkinson’s disease: A crit ical review of nine years’ experience. Can. Med. Assoc. J. 101 ,791–800.
4. Barbeau, A., Murphy, G.F. and Sourkes, T.L. (1961a). Excretion of dopamine in diseases of the basal ganglia. Science (Wash.) 133 ,1706–1707.
5. Barbeau, A., Sourkes, T.L. and Murphy, G.F. (1961b). Les catecholamines dans la maladie de Parkinson. In Monoamines et Systeme Neryeux CentraZ (de Ajuriaguerra, J., Ed.) pp. 247–262. Georg + Cie S.A., Geneva.